Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Thyroid hormones affect skin texture, hair and nail growth, and can cause skin diseases related to thyroid problems.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Alopecia areata in infants may be more common than previously thought.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Effective treatment improved skin and overall symptoms in a lupus patient.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

A woman with lupus and systemic sclerosis developed severe acne that didn't improve with treatment and died from pneumonia and septic shock.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.